Katherine Stueland Biography and Net Worth

Insider of Invitae

Katherine is passionate about how genetic information can help everyone make more informed healthcare decisions through testing and the power of a network that connects patients, clinicians, researchers, and patient communities to better inform what a patient can do with their diagnosis. With a relentless focus on opening up access for patients, she leads Invitae’s global commercial teams, including sales, international, biopharma partnerships, the direct ordering channel for patients, marketing, customer service, new market development, and communications/investor relations. Katherine cares deeply about the importance of broadening research to diverse patient populations to advance science and patient care for everyone. She previously led Invitae’s communications and investor relations team. Prior to joining Invitae, Katherine worked with management teams of biopharma companies, including serving as vice president of communications and investor relations at Dendreon, the first company to bring an immuno-oncology product to market. Katherine holds a B.S. in English Language and Literature from Miami University in Ohio.

What is Katherine Stueland's net worth?: The estimated net worth of Katherine Stueland is at least $31.63 as of October 29th, 2024. Ms. Stueland owns 105,426 shares of Invitae stock worth more than $32 as of November 18th. This net worth approximation does not reflect any other investments that Ms. Stueland may own. Learn More about Katherine Stueland's net worth.
How do I contact Katherine Stueland?: The corporate mailing address for Ms. Stueland and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (628) 213-3369 and via email at [email protected]. Learn More on Katherine Stueland's contact information.
Has Katherine Stueland been buying or selling shares of Invitae?: Katherine Stueland has not been actively trading shares of Invitae during the last quarter. Most recently, Katherine Stueland sold 20,340 shares of the business's stock in a transaction on Monday, June 14th. The shares were sold at an average price of $31.60, for a transaction totalling $642,744.00. Learn More on Katherine Stueland's trading history.
Who are Invitae's active insiders?: Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Shelly Guyer (CFO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO). Learn More on Invitae's active insiders.

Katherine Stueland Insider Trading History at Invitae

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2021	Sell	20,340	$31.60	$642,744.00
4/14/2021	Sell	19,893	$39.87	$793,133.91
3/15/2021	Sell	12,443	$42.90	$533,804.70
2/25/2021	Sell	5,000	$39.96	$199,800.00
1/13/2021	Sell	4,199	$51.82	$217,592.18
12/14/2020	Sell	34,300	$58.43	$2,004,149.00
11/13/2020	Sell	1,000	$48.00	$48,000.00
10/13/2020	Sell	1,000	$51.36	$51,360.00
9/15/2020	Sell	1,000	$35.51	$35,510.00
8/19/2020	Sell	21,345	$32.10	$685,174.50
8/12/2020	Sell	1,000	$29.31	$29,310.00
7/14/2020	Sell	1,000	$32.50	$32,500.00
6/12/2020	Sell	1,000	$16.34	$16,340.00
5/13/2020	Sell	1,000	$17.56	$17,560.00
4/13/2020	Sell	1,000	$12.80	$12,800.00
3/16/2020	Sell	10,684	$11.79	$125,964.36	224,786
3/13/2020	Sell	1,000	$11.64	$11,640.00	224,786
2/27/2020	Sell	1,000	$20.44	$20,440.00
1/14/2020	Sell	1,000	$18.14	$18,140.00
12/13/2019	Sell	1,000	$17.08	$17,080.00
11/14/2019	Sell	3,788	$17.46	$66,138.48
9/17/2019	Sell	3,788	$21.40	$81,063.20
8/16/2019	Sell	3,789	$24.98	$94,649.22
7/15/2019	Sell	3,789	$22.49	$85,214.61
6/13/2019	Sell	3,789	$19.36	$73,355.04
5/15/2019	Sell	1,000	$18.36	$18,360.00
4/16/2019	Sell	1,000	$25.23	$25,230.00
3/15/2019	Sell	1,000	$23.49	$23,490.00
2/27/2019	Sell	1,000	$19.61	$19,610.00
1/15/2019	Sell	1,000	$13.59	$13,590.00
12/17/2018	Sell	1,000	$11.44	$11,440.00
9/9/2018	Sell	595	$13.62	$8,103.90	191,963
9/12/2017	Sell	612	$9.40	$5,752.80	58,570

Katherine Stueland Buying and Selling Activity at Invitae

Invitae Company Overview

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Today's Range

Now: $0.00

$0.00

50 Day Range

MA: N/A

2 Week Range

Now: $0.00

$0.02

Volume

75 shs

Average Volume

23,716,614 shs

Market Capitalization

$80,103.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59

5 Stocks that could triple in a week

From Traders Agency | Ad

Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.

Click here to pay just $5 for a full year of Stealth Trades